ASP0113

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ASP0113, covering 2018-11-28 to 2024-10-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Tolerability of a Therapeutic Vaccine, ASP0113, in Subjects Undergoing Allogeneic Hematopoietic Cell Transplant [Phase 2]

See pricing